Ucb Biopharma Srl

This study tested a drug called bimekizumab in 509 adults with moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps and tunnels under the skin. The goal was to see if the drug could reduce these lesions by at least 50% after 16 weeks com…

This study tested a drug called bimekizumab in 505 adults with moderate to severe hidradenitis suppurativa, a chronic skin condition causing painful lumps. The goal was to see if the drug reduces skin abscesses and inflammation better than a placebo. Results focus on symptom impr…

This study tested a drug called bimekizumab in 400 adults with active psoriatic arthritis who had not improved with standard treatments. The goal was to see if the drug could reduce joint pain and swelling better than a placebo. Results showed significant improvement in arthritis…

This study tested a new drug, bimekizumab, in 852 adults with active psoriatic arthritis, a condition causing joint pain and swelling. Participants received either bimekizumab, a placebo, or an existing drug (adalimumab) for comparison. The main goal was to see if bimekizumab cou…

This study tested a drug called bimekizumab in 274 adults with a form of spinal arthritis that doesn't show up on X-rays (nonradiographic axial spondyloarthritis). The goal was to see if the drug could reduce pain, stiffness, and improve function better than a placebo. Participan…

This study tested an experimental oral medication, UCB0599, in 496 people with early-stage Parkinson's disease. Participants received either the drug or a placebo for 18 months. The goal was to see if UCB0599 could safely slow the worsening of Parkinson's symptoms, such as moveme…

This study tested an experimental drug called UCB0022 in 207 people with advanced Parkinson's disease. The goal was to see if adding UCB0022 to standard treatment (including levodopa) could reduce the daily hours when symptoms return, known as 'OFF' time. Participants were random…

This study tested a new medicine called UCB9741 in healthy people and those with moderate-to-severe atopic dermatitis (eczema). The goal was to check if the drug is safe and can improve skin symptoms. Researchers gave single or repeated doses and measured side effects and eczema …

This study involved 14 healthy adults to see if injecting zilucoplan with a prefilled syringe works the same as using an auto-injector. Researchers measured how much drug got into the blood and checked for side effects. The goal was to compare the two devices, not to treat any di…

This study looked at how much of the drug rozanolixizumab appears in breast milk after a single dose. Fifteen healthy women who were already planning to stop breastfeeding took part. Researchers collected milk samples over 7 days to measure drug levels and estimate how much a bab…